Accelerate Diagnostics: David Patience, Steve Reichling

Accelerate Diagnostics has named David Patience as its new CFO, effective April 1. He replaces Steve Reichling, who is stepping down to pursue other opportunities. Patience was previously senior director, head of business development and strategic finance at Accelerate. Prior to that, he was director, head of finance, planning and analysis and corporate development. Before joining Accelerate, Patience was with Morgan Stanley's investment banking division. He was also in equity research at Continental Advisors and held various financial research roles at Nuveen Investments. Reichling has been with Accelerate since 2012 and will remain in a consulting role with the firm through 2023.